1 What do we know about access to chronic disease medicines ? Dr Shanthi Mendis Coordinator Chronic Diseases Prevention and Management Department of Chronic.

Slides:

Advertisements

Similar presentations

UN High-Level Meeting puts NCDs on the map. Presentation 4 chapters 1. Who are/is behind is ? (stakeholders) – who is missing 2. What is at stake ? –

Advertisements

Patient Safety and Quality of Care: Role of the Compliance Professional Harvey V. Fineberg, M.D., Ph.D. Sixth Annual National Congress on Health Care Compliance.

1 Translation of Research Findings for Prevention and Control of NCDs Shanthi Mendis Chronic Disease Prevention and Management World Health Organization.

Direct costs and availability of diabetes medicines in low-income and middle-income countries Birgit Volman 27/08/2008 Meeting on Access to Medicines for.

MDG Target 8.E gap analysis Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical Policies, World Health Organization 27 August 2008.

ECOSOC Western Asia Ministerial Meeting Addressing noncommunicable diseases and injuries: major challenges to sustainable development in the 21st century.

National Scorecard, 2008: Chartpack This Chartpack presents data for all indicators scored in the National Scorecard on U.S. Health System Performance,

1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.

GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.

World Health Organization Department of Chronic Diseases and Health Promotion Global Initiative For Treatment of major chronic diseases Shanthi Mendis.

National Quality Strategy Overview August National Quality Strategy Introduction The Affordable Care Act (ACA) requires the Secretary of the Department.

Review of Health Inequalities at the local level Maggie Rae Head of Health Inequalities & Head of Local Delivery 11 May 2006.

National Quality Strategy Overview January 2014 Each slide includes notes that you can access by selecting “View” and then “Notes Page” in PowerPoint.

1 Integration of Noncommunicable Diseases into PHC in low-resource settings Lessons learned Dr Shanthi Mendis Chronic Disease Prevention and Management.

International and Canadian Perspectives on Integrated Chronic Disease Prevention Dr. Sylvie Stachenko Director General, Centre for Chronic Disease Prevention.

Dr. Sevil Huseynova World Health Organization

Essential Medicines Technical Briefing Seminar 1 |1 | Access to essential medicines for NCDs WHO EMP and NVI Departments Access to essential medicines.

Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.

Non-communicable diseases David Redfern

Noncommunicable Diseases & Health Promotion ICCC4, Seoul | 4 November 2011 | 1 | CV Profiling NCD and their risk factor in WHO Western Pacific Region Cherian.

What is an AEP?. AEPs specialise in clinical exercise interventions for a broad range of pathological populations.

1 NON COMMUNICABLE DISEASES NORTH -WESTERN PROVINCE Dr.M.D.S.RAJAMANTHRIE DPDHS Kurunegala Dr. D.I.WIJAYAWARDANA Medical Officer Planning PDHS Office.

Addressing the Challenge of NCDs in LAC: Brazil Country Case Study Isabella Danel Christoph Kurowski.

1 |1 | Conclusions of the Physical Activity Working Group Dr Godfrey Xuereb Team Leader Population-based Prevention Department of Chronic Diseases and.

WHO Technical Briefing Seminar on Essential Medicines & Health Products, October 2013 Noncommunicable Diseases –Action Plan Dr Shanthi Mendis Director,

Terms: Epidemiologic Transition Gaziano 2005 Stage 1Malnutrition and infectious diseases are the leading causes of mortality and morbidity Stage 2Improved.

Health System and Health System Strengthening in Nepal Dr BR Marasini, MBBS, MPH Senior Health Administrator Ministry of Health and Population.

Health system in Palestine Rawan shaaban

Developing Cardiac Rehabilitation in Vietnam Dr Juliette Hussey School of Medicine Trinity College Dublin Ireland.

Improving Life, One Breath at a Time 800-LUNGUSA

South Service Planning Area (SPA 6) and King-Drew Medical Center Health Needs Planning Data 2004 Compiled by LAC DHS Office of Planning, 2004.

- HEALTH PROMOTING HOSPITALS Dublin April 2005 WHO strategies on Noncommunicable diseases and Chronic care Jill Farrington Coordinator, Noncommunicable.

The Rising Prevalence of NCDs: Implications for Health Financing and Policy Charles Holmes, MD, MPH Office of the U.S. Global AIDS Coordinator Department.

NON COMMUNICABLE DISEASES( NCDs) By NSABIMANA Olivier Philemon, B.Pharm. ASEPA / UNR From 19/4-3/5 /2014.

Dr. Joseph Mbatia Assistant Director and Head, NCD, Mental Health and Substance Abuse Ministry of Health and Social Welfare (Tz. Mainland)

Global Alliance against Chronic Respiratory Diseases GARD/NCD Action Plan & 2011 UN Summit on NCDs Niels H. Chavannes MD PhD Associate.

Opportunities to Integrate NCDs into Existing Systems Lessons Learned from the HIV-Experience Astrid Permin, Senior Technical Adviser, TAS.

Reporter Shiu Ruei-Shiang Director of Adult and Elderly Health Bureau of Health Promotion.

Health Care Systems in a global perspective Margarita Mondaca A. Karolinska Institut

Source: WHO Global Burden of Disease Report Update 2004, Geneva 2008 Global Burden of Disease: chronic NCD responsible for high rates of premature mortality.

A Healthy Future More prevention – earlier intervention East Lancashire Teaching PCT’s Strategic Commissioning Plan.

Call to action on NCDs: Challenges and Way Forward for Maternal and Child Health Dr. Niloufer Sultan Ali Professor, Family Medicine Aga Khan University,

The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.

Diabetes: 0–44 years Ranked comorbidity combinations Source: ABS Australian Health Survey 2011–12 (National Health Survey component) For people aged 0–44,

(A)In Developed Countries *diseases of modernisation. *over eating &non blalanced diets *Alcoholism *Smoking *overuse of hard drugs *Worry.

An Overview of the Burden of Non- Communicable Diseases (NCDs) Dr Sylvia J Anie Director Social Transformation Programmes Division (Education, Health,

World Health Organization Non-communicable disease prevention and control: key messages 1.Non-communicable diseases are a major public health and socio-

Nick Banatvala & Pascal Bovet

Non-communicable diseases (NCDs) include:

Kingdom of Bahrain Dr. Naeema Isa Al Sabaeei 2014

NCD policy and programming in Croatia

Chronic NCDs in Sri Lanka : Policy to Public Health approaches

Outlines towards National NCDs Prevention and Control Strategy

DR GHULAM NABI KAZI WHO Country Office Pakistan

Implementing a National NCD Program Population Based and High Risk Approaches to Prevention and Control of NCDs/CVD Dr Shanthi Mendis MBBS MD FRCP.

Chronic respiratory diseases: burden, population and interventions,

World Health Organization

Epidemiology, Burden and Primary Prevention of Cardiovascular Disease Dr Shanthi Mendis MBBS MD FRCP FACC Coordinator Chronic Disease Prevention.

South Norfolk CCG Profile

Somali Federal Republic Ministry of Health

Prevention and Control of Noncommunicable Diseases

How does teamwork improve value. Dr Nils E

prevention and control of non communicable diseases in Iraq

GARD/NCD Action Plan & 2011 UN Summit on NCDs

Non-communicable diseases (NCDs) include:

European Strategy for the Prevention and Control of Noncommunicable Diseases & Strategies for Promotion of Healthy Lifestyles St Petersburg. Russian Federation.

NCD – Kingdom of Saudi Arabia

Epidemiological Terms

Dr Ruitai Shao Programme Management Adviser

World Health Organization

Presentation transcript:

1 What do we know about access to chronic disease medicines ? Dr Shanthi Mendis Coordinator Chronic Diseases Prevention and Management Department of Chronic Diseases and Health Promotion World Health Organization

2 Noncommunicable Diseases Cost effective interventions Cardiovascular disease Cardiovascular disease Chronic lung disease Chronic lung disease Diabetes Diabetes

3 Global mortality Cardiovascular diseases 30% Cancer 13% Other NCDs, injuries Other NCDs, injuries & mental health 18% Communicable maternal maternal infant 30% infant 30% Respiratory7% Diabetes 2%

Essential Complimentary Strategies for NCD prevention and control NCD prevention and control Population- wide Primary prevention in high risk groups Secondary prevention

5 Overall Percentage in 10 countries Secondary Prevention of Heart Disease WHO PREMISE 2003 Bulletin of the WHO 2005;83; Percentage Drugs

6 Affordability and Availability of 32 medicines for NCDs in 6 LMIC< 7.5% of the medicines available in public sector Cost of medicines in the private sector high Affordability and Availability of 32 medicines for NCDs in 6 LMIC< 7.5% of the medicines available in public sector Cost of medicines in the private sector high

7 Affordability Number of days' wages for 1 month medicines after a heart attack WHO 2006 Days

8 Access to medicines for diabetes, asthma, CVD Is it equitable ? Do patients with Type I diabetes die because they are too poor to get insulin? Do asthma get hospitalized with acute attacks because they cannot afford asthma medicines? Can heart disease patients e who earn a daily wage afford to buy medicines?

9 Thank You